Search
Scientists have found a protein that empowers prostate tumors to resist hormone therapy.
On Thursday, June 11, at 11:30 AM, 45 high school seniors will participate in the MSK Kids 14th Annual Convocation ceremony. Each year, MSK celebrates our youngest patients (who have all battled cancer or a blood disorder) who are receiving their high school diploma or equivalency.
New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow.
Recently, dozens of survivors, their parents, and members of the Memorial Sloan Kettering Cancer Center (MSK) Department of Pediatrics joined the Times Square Advertising Coalition to turn the bright lights of Times Square gold to raise awareness for pediatric cancer.
A Memorial Sloan Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates.
A new type of CAR T cell therapy for multiple myeloma could shorten the time to treatment.
The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics.
Kenneth Manotti has been named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center (MSK).
Learn about how cognitive behavioral therapy for insomnia (CBT-I) helps people with cancer improve sleep.
Learn about a new vaccine at MSK that could prevent neuroblastoma from returning after treatment.